BioNTech SE Operating Income 2011-2026 | BNTX

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income BioNTech SE

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	15.3 B	-82.4 M	-182 M	-53.9 M	-61.3 M	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
15.3 B	-182 M	2.98 B

Operating Income of other stocks in the Biotechnology industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-508 M	-	2.43 %	$ 254 M	Germany
Aeterna Zentaris AEZS	-8.67 M	-	5.93 %	$ 314 M	Canada
Adagene ADAG	-36 M	$ 1.9	-3.11 %	$ 107 M	China
Acorda Therapeutics ACOR	-265 M	-	-24.86 %	$ 820 K	USA
AgeX Therapeutics AGE	-9.89 M	-	-10.17 %	$ 12.2 K	USA
Aytu BioScience AYTU	-7.83 M	$ 2.71	1.88 %	$ 17 M	USA
Amphastar Pharmaceuticals AMPH	205 M	$ 25.87	-0.79 %	$ 1.25 B	USA
Aravive ARAV	-70.8 M	-	-13.39 %	$ 1.45 M	USA
AVROBIO AVRO	10.2 M	-	1083.1 %	$ 745 M	USA
Biophytis SA BPTS	-26.8 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	-209 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	-7 M	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	-285 M	-	-	$ 3.67 B	USA
Brickell Biotech BBI	-6.36 M	-	-5.38 %	$ 6.06 M	USA
BioLineRx Ltd. BLRX	-24.8 M	$ 2.97	3.12 %	$ 908 M	Israel
BeiGene, Ltd. BGNE	-568 M	-	0.49 %	$ 251 B	Cayman-islands
Akouos AKUS	-86.8 M	-	0.23 %	$ 488 M	USA
Applied Molecular Transport AMTI	-127 M	-	-	$ 10.1 M	USA
Ascendis Pharma A/S ASND	-452 M	$ 215.29	4.59 %	$ 5 B	Danmark
Bellicum Pharmaceuticals BLCM	-27 M	-	-9.72 %	$ 5.89 M	USA
ARCA biopharma ABIO	-88.1 M	-	1052.0 %	$ 415 M	USA
Bio-Path Holdings BPTH	-15.8 M	-	-	$ 100 K	USA
Acasti Pharma ACST	-16.7 M	-	4.01 %	$ 150 M	Canada
Baudax Bio BXRX	-56.8 M	-	0.59 %	$ 63 K	USA
Arrowhead Pharmaceuticals ARWR	98.3 M	$ 64.74	1.41 %	$ 8.66 B	USA
Can-Fite BioPharma Ltd. CANF	-8.13 M	$ 3.96	-1.0 %	$ 8.62 B	Israel
Burford Capital Limited BUR	242 M	$ 9.63	-0.93 %	$ 1.56 B	Britain
CASI Pharmaceuticals CASI	-41.8 M	$ 0.95	-0.72 %	$ 129 M	USA
Ayala Pharmaceuticals AYLA	-37.5 M	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	-140 M	-	-15.15 %	$ 60.3 M	Britain
Celldex Therapeutics CLDX	-195 M	$ 25.15	-1.95 %	$ 1.62 M	USA
AIkido Pharma AIKI	-11.5 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	-123 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	-412 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	-24.6 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	-58.1 M	-	-	$ 2.17 B	USA
AlloVir ALVR	-65.4 M	-	4.14 %	$ 49.1 M	USA
Catalyst Biosciences CBIO	-67.2 M	$ 14.01	3.7 %	$ 922 M	USA
Ampio Pharmaceuticals AMPE	-33.3 M	-	-11.43 %	$ 502 K	USA
Biogen BIIB	7.04 B	$ 164.87	0.27 %	$ 24 B	USA
Avid Bioservices CDMO	-18.7 M	-	-	$ 789 M	USA
BioVie BIVI	-18.1 M	$ 1.23	2.07 %	$ 1.82 M	USA
Catalyst Pharmaceuticals CPRX	195 M	$ 23.32	2.71 %	$ 2.76 B	USA
Calithera Biosciences CALA	-115 M	-	-10.95 %	$ 876 K	USA